Malhar Chemicals engages in the manufacturing and development of Active Pharmaceutical Ingredients (API) and New Chemical Entities (NCE), API intermediates, Regulatory Starting Materials (RSM), Basic Starting Materials, Key Building Blocks, and Xanthine Derivatives for use in clinical testing and commercial production. In addition to process R&D, we provide stability studies, scale-up and process optimisation, process validations, and commercial manufacturing.
|
|
AUTOMATED MANUFACTURING |
|
COMPLETELY BACKWARD INTEGRATED |
|
GAMP 5 compliant, Distributed Control System (DCS) enabled manufacturing line that provides excellent control over operating parameters to deliver consistent quality output batch over batch. |
Our manufacturing facilities are both independent as well as integrable with each other; starting from fine chemicals to advanced pharmaceutical intermediates to APIs. |
||
|
|
|||
|
|
RICH LEARNING ENVIRONMENT |
|
QUALITY & INTEGRITY |
|
Our employees enjoy a rich learning-oriented atmosphere, enabling them to reach global standards and become a benchmark for knowledge. |
Our approach to quality and Integrity is transparency. Our facilities and systems are designed based on QbD principles. |
||
To emerge as a “global partner of choice” for leading.
Sustainable delivery and business operations for our products and Services.
Our devotion to caregiving spans all of our stakeholders, including our team members, clients, suppliers, local community, and the environment.
We consistently uphold the greatest moral and ethical principles.
We endeavour to gratify our clients and stakeholders.
